Globus Medical, Inc.
GMED
주식 순위
#1980
Globus Medical, Inc. is a global medical technology company dedicated to... Globus Medical, Inc. is a global medical technology company dedicated to inventing, developing, and marketing a diverse range of healthcare solutions. Their primary focus is on addressing musculoskeletal disorders for patients worldwide. Their extensive portfolio includes a variety of spinal products. These encompass traditional fusion implants like pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices, all designed to treat conditions such as degenerative diseases, deformities, tumors, and trauma. Furthermore, they offer advanced motion preservation technologies, including dynamic stabilization, total disc replacement, and interspinous distraction devices. The company also provides interventional pain management options for vertebral compression fractures, alongside a selection of regenerative biologic products such as allografts and synthetic alternatives. Beyond spinal care, Globus Medical manufactures solutions for orthopedic trauma, featuring products like fracture plates, compression screws, intramedullary nails, and external fixation systems. They also specialize in hip and knee joint reconstruction, offering modular hip stems, acetabular cups, and various knee arthroplasty implants, including posterior stabilizing and cruciate retaining designs. Additionally, the company engages in the distribution of human cell, tissue, and other cellular and tissue-based products. Established in 2003, Globus Medical, Inc. maintains its corporate headquarters in Audubon, Pennsylvania.
주가
$79.05
시가총액
$10.61B
변동 (1일)
4.29%
변동 (1년)
28.37%
국가
US
거래 Globus Medical, Inc. (GMED)
카테고리
Healthcare
Globus Medical, Inc. (GMED)의 P/S 비율
October 2026 기준 P/S 비율 TTM: 3.26
Globus Medical, Inc.의 최신 재무 보고서와 주가에 따르면 현재 P/S 비율(TTM)은 3.26입니다. 2023년 말 기준 P/S 비율은 3.84였습니다.
Globus Medical, Inc.의 P/S 비율 기록 (2009 ~ 2026)
매년 말 P/S 비율
| 연도 | P/S 비율 | 변화 |
|---|---|---|
| 2026 (TTM) | 3.26 | -26.96% |
| 2024 | 4.46 | 15.97% |
| 2023 | 3.84 | -47.33% |
| 2022 | 7.30 | -3.90% |
| 2021 | 7.59 | -6.84% |
| 2020 | 8.15 | 9.62% |
| 2019 | 7.43 | 25.10% |
| 2018 | 5.94 | -4.47% |
| 2017 | 6.22 | 47.82% |
| 2016 | 4.21 | -13.32% |
| 2015 | 4.85 | 2.80% |
| 2014 | 4.72 | 9.72% |
| 2013 | 4.30 | 76.71% |
| 2012 | 2.44 | -17.74% |
| 2011 | 2.96 | -13.06% |
| 2010 | 3.41 | -27.19% |
| 2009 | 4.68 | 0.00% |
유사 기업 또는 경쟁사의 P/S 비율
| 회사 | P/S 비율 | P/S 비율 차이 | 국가 |
|---|---|---|---|
| 3.82 | 17.40% |
US
|
|
| 2.78 | -14.52% |
IE
|
|
| 4.18 | 28.27% |
US
|
|
| 2.97 | -8.82% |
US
|
|
| - | - |
DE
|
